vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and InterDigital, Inc. (IDCC). Click either name above to swap in a different company.

InterDigital, Inc. is the larger business by last-quarter revenue ($158.2M vs $138.3M, roughly 1.1× Core Laboratories Inc.). InterDigital, Inc. runs the higher net margin — 27.2% vs 5.3%, a 21.9% gap on every dollar of revenue. On growth, Core Laboratories Inc. posted the faster year-over-year revenue change (2.8% vs -37.4%). InterDigital, Inc. produced more free cash flow last quarter ($528.6M vs $5.1M). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (2.9% CAGR vs -22.5%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

InterDigital, Inc. is an American technology research and development company that provides wireless and video technologies for mobile devices, networks, and services worldwide. Founded in 1972, InterDigital is listed on the Nasdaq and is included in the S&P 600 index.

CLB vs IDCC — Head-to-Head

Bigger by revenue
IDCC
IDCC
1.1× larger
IDCC
$158.2M
$138.3M
CLB
Growing faster (revenue YoY)
CLB
CLB
+40.2% gap
CLB
2.8%
-37.4%
IDCC
Higher net margin
IDCC
IDCC
21.9% more per $
IDCC
27.2%
5.3%
CLB
More free cash flow
IDCC
IDCC
$523.4M more FCF
IDCC
$528.6M
$5.1M
CLB
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
2.9%
-22.5%
IDCC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
IDCC
IDCC
Revenue
$138.3M
$158.2M
Net Profit
$7.3M
$43.0M
Gross Margin
Operating Margin
11.5%
30.2%
Net Margin
5.3%
27.2%
Revenue YoY
2.8%
-37.4%
Net Profit YoY
1.2%
-67.7%
EPS (diluted)
$0.16
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
IDCC
IDCC
Q1 26
$138.3M
Q4 25
$138.3M
$158.2M
Q3 25
$134.5M
$164.7M
Q2 25
$130.2M
$300.6M
Q1 25
$123.6M
$210.5M
Q4 24
$129.2M
$252.8M
Q3 24
$134.4M
$128.7M
Q2 24
$130.6M
$223.5M
Net Profit
CLB
CLB
IDCC
IDCC
Q1 26
$7.3M
Q4 25
$4.9M
$43.0M
Q3 25
$14.2M
$67.5M
Q2 25
$10.6M
$180.6M
Q1 25
$-154.0K
$115.6M
Q4 24
$7.4M
$133.1M
Q3 24
$11.7M
$34.2M
Q2 24
$9.0M
$109.7M
Gross Margin
CLB
CLB
IDCC
IDCC
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
IDCC
IDCC
Q1 26
11.5%
Q4 25
11.5%
30.2%
Q3 25
15.6%
46.0%
Q2 25
11.7%
68.3%
Q1 25
3.6%
62.6%
Q4 24
11.0%
64.3%
Q3 24
14.7%
30.6%
Q2 24
12.3%
59.9%
Net Margin
CLB
CLB
IDCC
IDCC
Q1 26
5.3%
Q4 25
3.6%
27.2%
Q3 25
10.6%
41.0%
Q2 25
8.2%
60.1%
Q1 25
-0.1%
54.9%
Q4 24
5.7%
52.7%
Q3 24
8.7%
26.6%
Q2 24
6.9%
49.1%
EPS (diluted)
CLB
CLB
IDCC
IDCC
Q1 26
$0.16
Q4 25
$0.11
$1.07
Q3 25
$0.30
$1.93
Q2 25
$0.22
$5.35
Q1 25
$0.00
$3.45
Q4 24
$0.15
$4.12
Q3 24
$0.25
$1.14
Q2 24
$0.19
$3.93

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
IDCC
IDCC
Cash + ST InvestmentsLiquidity on hand
$22.8M
$1.2B
Total DebtLower is stronger
$16.3M
Stockholders' EquityBook value
$279.8M
$1.1B
Total Assets
$597.0M
$2.1B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
IDCC
IDCC
Q1 26
$22.8M
Q4 25
$22.7M
$1.2B
Q3 25
$25.6M
$1.3B
Q2 25
$31.2M
$937.0M
Q1 25
$22.1M
$883.3M
Q4 24
$19.2M
$958.2M
Q3 24
$21.5M
$813.2M
Q2 24
$17.7M
$760.3M
Total Debt
CLB
CLB
IDCC
IDCC
Q1 26
Q4 25
$110.3M
$16.3M
Q3 25
$114.1M
$17.1M
Q2 25
$124.6M
$16.6M
Q1 25
$124.4M
$16.0M
Q4 24
$126.1M
$15.4M
Q3 24
$139.9M
$18.3M
Q2 24
$147.6M
$17.7M
Stockholders' Equity
CLB
CLB
IDCC
IDCC
Q1 26
$279.8M
Q4 25
$266.0M
$1.1B
Q3 25
$271.3M
$1.1B
Q2 25
$261.3M
$1.1B
Q1 25
$253.4M
$936.9M
Q4 24
$246.6M
$857.2M
Q3 24
$250.7M
$722.5M
Q2 24
$240.3M
$696.8M
Total Assets
CLB
CLB
IDCC
IDCC
Q1 26
$597.0M
Q4 25
$584.0M
$2.1B
Q3 25
$591.4M
$2.1B
Q2 25
$602.1M
$2.0B
Q1 25
$591.5M
$1.9B
Q4 24
$585.1M
$1.8B
Q3 24
$600.5M
$1.7B
Q2 24
$597.8M
$1.6B
Debt / Equity
CLB
CLB
IDCC
IDCC
Q1 26
Q4 25
0.41×
0.01×
Q3 25
0.42×
0.02×
Q2 25
0.48×
0.02×
Q1 25
0.49×
0.02×
Q4 24
0.51×
0.02×
Q3 24
0.56×
0.03×
Q2 24
0.61×
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
IDCC
IDCC
Operating Cash FlowLast quarter
$37.2M
$544.5M
Free Cash FlowOCF − Capex
$5.1M
$528.6M
FCF MarginFCF / Revenue
3.7%
334.0%
Capex IntensityCapex / Revenue
10.0%
Cash ConversionOCF / Net Profit
5.12×
12.67×
TTM Free Cash FlowTrailing 4 quarters
$27.1M
$994.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
IDCC
IDCC
Q1 26
$37.2M
Q4 25
$7.9M
$544.5M
Q3 25
$8.5M
$395.9M
Q2 25
$13.9M
$105.1M
Q1 25
$6.7M
$-20.0M
Q4 24
$20.6M
$271.5M
Q3 24
$13.1M
$77.6M
Q2 24
$17.1M
$-48.9M
Free Cash Flow
CLB
CLB
IDCC
IDCC
Q1 26
$5.1M
Q4 25
$5.0M
$528.6M
Q3 25
$6.5M
$395.3M
Q2 25
$10.4M
$104.5M
Q1 25
$3.9M
$-34.5M
Q4 24
$17.4M
$265.7M
Q3 24
$10.4M
$76.7M
Q2 24
$14.3M
$-49.5M
FCF Margin
CLB
CLB
IDCC
IDCC
Q1 26
3.7%
Q4 25
3.6%
334.0%
Q3 25
4.8%
240.1%
Q2 25
8.0%
34.8%
Q1 25
3.1%
-16.4%
Q4 24
13.4%
105.1%
Q3 24
7.7%
59.6%
Q2 24
10.9%
-22.1%
Capex Intensity
CLB
CLB
IDCC
IDCC
Q1 26
Q4 25
2.1%
10.0%
Q3 25
1.5%
0.4%
Q2 25
2.7%
0.2%
Q1 25
2.3%
6.9%
Q4 24
2.5%
2.3%
Q3 24
2.0%
0.7%
Q2 24
2.2%
0.3%
Cash Conversion
CLB
CLB
IDCC
IDCC
Q1 26
5.12×
Q4 25
1.61×
12.67×
Q3 25
0.60×
5.87×
Q2 25
1.31×
0.58×
Q1 25
-0.17×
Q4 24
2.78×
2.04×
Q3 24
1.12×
2.27×
Q2 24
1.90×
-0.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons